BKT300: A Novel Anti-Leukemic Small Molecule Targeting the Protein Regulator of Cytokinesis 1 (PRC1) Pathway.

BKT-300 - Biokine Therap

http://www.ncbi.nlm.nih.gov/pubmed/40034437

Amnon Peled; Arnon Aharon; Edward Ayoub; Gautam Borthakur; Hanna Wald; Jonathan Monin; Lika Gamaev; Michael Andreeff; Michal Abraham; Ophir Hay; Orly Eizenberg; Rakefet Rosenfeld; Shira Hagbi

Mar 4, 2025